CY1106452T1 - Παραγωγα του υδροξαμικου οξεως ως αντιβακτηριακα - Google Patents
Παραγωγα του υδροξαμικου οξεως ως αντιβακτηριακαInfo
- Publication number
- CY1106452T1 CY1106452T1 CY20071100285T CY071100285T CY1106452T1 CY 1106452 T1 CY1106452 T1 CY 1106452T1 CY 20071100285 T CY20071100285 T CY 20071100285T CY 071100285 T CY071100285 T CY 071100285T CY 1106452 T1 CY1106452 T1 CY 1106452T1
- Authority
- CY
- Cyprus
- Prior art keywords
- alkyl
- group
- bacterial
- independently
- alk
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- -1 hydroxy, mercapto Chemical class 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Οι ενώσεις τύπου (I) είναι αντιβακτηριακά όπου: το R1 παριστά υδρογόνο ή αλκύλιο με C1-C6 ή αλκύλιο με C1-C6 υποκατασταθέν με ένα ή περισσότερα άτομα αλογόνου˙ το R2 παριστά μία ομάδα R10-(X)n-(ALK)m- όπου το R10 παριστά υδρογόνο ή αλκύλιο με C1-C6, αλκενύλιο με C2-C6, αλκυνύλιο με C2-C6, ομάδα κυκλοαλκυλίου, αρυλίου ή ετεροκυκλυλίου, οποιοδήποτε από τα οποία μπορεί να είναι μη υποκατασταθέν ή υποκατασταθέν με αλκύλιο με C1-C6, αλκοξύλιο με C1-C6, υδροξύλιο, μερκαπτοομάδα, αλκυλθείο με C1-C6, αμίνη, αλογόνο (περιλαμβάνον φθόριο, χλώριο, βρώμιο και ιώδιο), τριφθορομεθύλιο, κυάνιο, νιτροομάδα, -COOH, -CONH2, -COORA, -NHCORA, -CONHRA, -NHRA, -NRARB ή -CONRARB όπου τα RA και RB είναι ανεξάρτητα ομάδα αλκυλίου με C1-C6 και το ALK παριστά μία ευθεία ή διακλαδούμενη δισθενή ρίζα αλκυλενίου με C1-C6, αλκενυλενίου με C2-C6 ή αλκυνυλενίου με C2-C6 και μπορεί να διακόπτεται από έναν ή περισσότερους μη γειτονικούς δεσμούς -ΝΗ-, -Ο- ή -S-, το Χ παριστά -ΝΗ-, -Ο- ή -S- και τα m και n είναι ανεξάρτητα 0 ή 1 ˙ και το Α παριστά μία ομάδα όπως ορίζεται στην περιγραφή.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810464.9A GB9810464D0 (en) | 1998-05-16 | 1998-05-16 | Hydroxamic acid derivatives |
| PCT/GB1999/001541 WO1999059568A1 (en) | 1998-05-16 | 1999-05-14 | Hydroxamic acid derivatives as antibacterials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106452T1 true CY1106452T1 (el) | 2011-10-12 |
Family
ID=10832125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100285T CY1106452T1 (el) | 1998-05-16 | 2007-03-01 | Παραγωγα του υδροξαμικου οξεως ως αντιβακτηριακα |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6441042B1 (el) |
| EP (2) | EP1754477A3 (el) |
| JP (1) | JP2002515427A (el) |
| KR (1) | KR100634089B1 (el) |
| CN (1) | CN1300210A (el) |
| AT (1) | ATE347356T1 (el) |
| AU (1) | AU754063B2 (el) |
| BR (1) | BR9910488A (el) |
| CA (1) | CA2332713C (el) |
| CY (1) | CY1106452T1 (el) |
| DE (1) | DE69934309T2 (el) |
| DK (1) | DK1079819T3 (el) |
| ES (1) | ES2278444T3 (el) |
| GB (2) | GB9810464D0 (el) |
| HU (1) | HUP0102290A3 (el) |
| IL (2) | IL139059A0 (el) |
| NO (1) | NO20005782L (el) |
| NZ (1) | NZ507560A (el) |
| PL (1) | PL344438A1 (el) |
| PT (1) | PT1079819E (el) |
| TR (1) | TR200003376T2 (el) |
| WO (1) | WO1999059568A1 (el) |
| ZA (1) | ZA200006131B (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
| GB9810464D0 (en) * | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
| DE69924887T2 (de) * | 1999-08-10 | 2006-03-09 | Vernalis (Oxford) Ltd., Abington | Antibakterielle mittel |
| FR2801591B1 (fr) * | 1999-11-30 | 2002-03-01 | Aventis Pharma Sa | Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent |
| AU2180201A (en) * | 1999-11-30 | 2001-06-12 | Aventis Pharma S.A. | Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same |
| GB9929979D0 (en) * | 1999-12-17 | 2000-02-09 | Darwin Discovery Ltd | Hydroxamic acid derivatives |
| CA2393825A1 (en) * | 1999-12-17 | 2001-06-21 | Versicor, Inc. | Novel succinate compounds, compositions and methods of use and preparation |
| AU2002230385A1 (en) * | 2000-09-25 | 2002-04-15 | Questcor Pharmaceuticals, Inc. | Peptide deformylase inhibitors |
| DE60111768T2 (de) | 2000-11-23 | 2006-04-27 | Vernalis (Oxford) Ltd., Abington | N-formyl hydroxylamine derivate als inhibitoren der bakteriellen polypeptid deformylase zur behandlung von mikrobiellen infektionen |
| US6660741B2 (en) * | 2001-03-19 | 2003-12-09 | Sloan-Kettering Institute For Cancer Research | Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| US20040267015A1 (en) * | 2001-04-05 | 2004-12-30 | Ajita Bhat | Peptide deformylase inhibitors |
| GB0128943D0 (en) * | 2001-12-04 | 2002-01-23 | Novo Pharmaceuticals De Ltd | Bacterial enzyme inhibitors |
| JP4190862B2 (ja) * | 2001-12-18 | 2008-12-03 | シャープ株式会社 | 表示装置およびその駆動方法 |
| GB0208579D0 (en) * | 2002-04-13 | 2002-05-22 | British Biotech Pharm | Antibacterial agents |
| DE10320453A1 (de) * | 2003-05-08 | 2004-11-25 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Bioisostere von Actinonin |
| PL3075401T3 (pl) | 2007-11-29 | 2024-08-19 | Inolex Investment Corporation | Środek konserwujący dla kompozycji kosmetycznych, toaletowych i farmaceutycznych |
| DE102011088962A1 (de) * | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Wirkstoffkombinationen aus einer oder mehreren Carbonsäuren, insbesondereHydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologische Zubereitungen, solcheWirkstoffkombinationen enthaltend |
| WO2016201288A1 (en) | 2015-06-12 | 2016-12-15 | Brown University | Novel antibacterial compounds and methods of making and using same |
| WO2019005064A1 (en) * | 2017-06-29 | 2019-01-03 | Kimberly-Clark Worldwide, Inc. | ANTIMICROBIAL COMPOSITION COMPRISING DIHYDROXAMIC ACID AND METHODS OF INHIBITING MICROBIAL PROLIFERATION USING THE SAME |
| CN108672095A (zh) * | 2018-05-04 | 2018-10-19 | 广东省资源综合利用研究所 | γ-羟基烷基羟肟酸及其制备方法与应用 |
| US11555010B2 (en) | 2019-07-25 | 2023-01-17 | Brown University | Diamide antimicrobial agents |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1028921A (en) * | 1962-01-23 | 1966-05-11 | Ranjeet Bhagwan Singh | New antibiotic |
| US4303662A (en) * | 1980-11-24 | 1981-12-01 | E. R. Squibb & Sons, Inc. | Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds |
| JPH0670019B2 (ja) * | 1989-07-21 | 1994-09-07 | 明治製菓株式会社 | 新抗生物質ｓｆ２１９７ｃ物質およびその製造法 |
| GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
| JPH03157372A (ja) * | 1989-11-13 | 1991-07-05 | Yamanouchi Pharmaceut Co Ltd | Ｙｌ―０１８６９ｐ物質及びその製造法 |
| AU2228292A (en) * | 1991-06-14 | 1993-01-12 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| EP0715619A4 (en) * | 1993-08-23 | 1997-03-19 | Immunex Corp | INHIBITORS OF TNF-ALPHA SECRETION |
| JP3157372B2 (ja) | 1993-11-29 | 2001-04-16 | 三洋電機株式会社 | フィルタ |
| US5962529A (en) * | 1994-06-22 | 1999-10-05 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
| US5532265A (en) * | 1994-11-30 | 1996-07-02 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors |
| GB9507799D0 (en) * | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
| US6281245B1 (en) * | 1996-10-28 | 2001-08-28 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| ATE290878T1 (de) * | 1996-12-06 | 2005-04-15 | Fonden Til Fremme Af Eksperime | Inhibierung von invasiver remodulierung |
| ZA9711121B (en) * | 1996-12-13 | 1998-06-23 | Handelman Joseph H | Reduction of hair growth. |
| WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
| GB9810464D0 (en) * | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
-
1998
- 1998-05-16 GB GBGB9810464.9A patent/GB9810464D0/en not_active Ceased
-
1999
- 1999-05-14 WO PCT/GB1999/001541 patent/WO1999059568A1/en active IP Right Grant
- 1999-05-14 PL PL99344438A patent/PL344438A1/xx unknown
- 1999-05-14 PT PT99922317T patent/PT1079819E/pt unknown
- 1999-05-14 DE DE69934309T patent/DE69934309T2/de not_active Expired - Fee Related
- 1999-05-14 BR BR9910488-1A patent/BR9910488A/pt not_active Application Discontinuation
- 1999-05-14 HU HU0102290A patent/HUP0102290A3/hu unknown
- 1999-05-14 JP JP2000549233A patent/JP2002515427A/ja not_active Withdrawn
- 1999-05-14 AT AT99922317T patent/ATE347356T1/de not_active IP Right Cessation
- 1999-05-14 CN CN99806057A patent/CN1300210A/zh active Pending
- 1999-05-14 KR KR1020007012819A patent/KR100634089B1/ko not_active IP Right Cessation
- 1999-05-14 EP EP06009622A patent/EP1754477A3/en not_active Withdrawn
- 1999-05-14 TR TR2000/03376T patent/TR200003376T2/xx unknown
- 1999-05-14 GB GB0024789A patent/GB2353708A/en not_active Withdrawn
- 1999-05-14 EP EP99922317A patent/EP1079819B1/en not_active Expired - Lifetime
- 1999-05-14 CA CA002332713A patent/CA2332713C/en not_active Expired - Fee Related
- 1999-05-14 DK DK99922317T patent/DK1079819T3/da active
- 1999-05-14 NZ NZ507560A patent/NZ507560A/xx unknown
- 1999-05-14 ES ES99922317T patent/ES2278444T3/es not_active Expired - Lifetime
- 1999-05-14 IL IL13905999A patent/IL139059A0/xx not_active IP Right Cessation
- 1999-05-14 US US09/700,424 patent/US6441042B1/en not_active Expired - Fee Related
- 1999-05-14 AU AU39421/99A patent/AU754063B2/en not_active Ceased
-
2000
- 2000-10-16 IL IL139059A patent/IL139059A/en unknown
- 2000-10-30 ZA ZA200006131A patent/ZA200006131B/en unknown
- 2000-11-15 NO NO20005782A patent/NO20005782L/no not_active Application Discontinuation
-
2002
- 2002-06-26 US US10/179,227 patent/US6992190B2/en not_active Expired - Fee Related
-
2005
- 2005-08-22 US US11/207,813 patent/US7323563B2/en not_active Expired - Fee Related
-
2007
- 2007-03-01 CY CY20071100285T patent/CY1106452T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106452T1 (el) | Παραγωγα του υδροξαμικου οξεως ως αντιβακτηριακα | |
| WO1999039704A8 (en) | Antibacterial agents | |
| AP2001002205A0 (en) | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase. | |
| SE9900100D0 (sv) | New compounds | |
| ES2187473T3 (es) | Triarylimidazoles. | |
| PT842934E (pt) | Agonistas de 5-ht1f | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| CY1113487T1 (el) | Νεα παραγωγα μανδελικου οξεος και η χρηση τους ως αναστολεις θροβινης | |
| CY1111148T1 (el) | Ιμιδαζο- και τριαζολοπυριδινες ως αναστολεις της 11β-υδροξυστεροειδικης αφυδρογονασης τυπου i | |
| IL144464A0 (en) | N<2>-phenylamidine derivatives | |
| YU401A (sh) | Sredstva sa antidepresivnim dejstvom | |
| CY1104970T1 (el) | Προϊοντα συζευξης γλυκοπυρανοσιδιων των 2-(4-υδροξυ-φαινυλ)-1-[4-(2-αμιν-1-υλ-αιθοξυ)-βενζυλ]-1η-ινδολ-5-ολων | |
| DK1113011T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
| CY1104996T1 (el) | 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν | |
| BR9909898A (pt) | Processo para purificação de um derivado de cefalosporina | |
| HUP0400867A2 (hu) | Eljárás ciklohexanolszármazékok előállítására | |
| GB9827805D0 (en) | Antibacterial agents | |
| TR200103143T2 (tr) | 9-Deokso-9A-AZA-9A-Homeritromisin 9A'nın Halo Türevleri. | |
| BR9909029A (pt) | Estabilização de poliisocianatos orgânicos | |
| BR9902096A (pt) | Pitazóis. | |
| ES2159489A1 (es) | Nuevos derivados de imidazol con actividad antiinflamatoria. | |
| CY1112574T1 (el) | Οκταπεπτιδιο το οποιο εχει αντιαγγειογενετικη δραστικοτητα | |
| DE69729098D1 (de) | Fluorierung von ketoamiden | |
| DE69915688D1 (de) | Benzonaphtyridin-1,8 derivate | |
| ES2185495B1 (es) | Soporte publicitario universal para puertas. |